Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Eczema Health Center

Font Size

'Black Box' Warning for 2 Eczema Drugs

FDA Approves Content for Warning on Elidel, Protopic Creams
WebMD Health News
Reviewed by Louise Chang, MD

Jan. 19, 2006 -- The FDA has approved the "black box" warning that two prescription eczema drugs will carry.

The FDA announced in March 2005 that two topical eczema drugs -- Elidel cream and Protopic ointment -- would get a "black box" warning about a possible cancer risk. A "black box" warning is the FDA's strongest warning.

An FDA committee had recommended the warning in February 2005. Now, the FDA has approved the warning's content.

The warning states that there have been rare reports of cancer (for example, skin and lymphoma) in patients who had been receiving the two drugs, says an FDA news release. However, the drugs haven't been proven to cause cancer, says the FDA.

The drugs' makers are studying cancer risk, but it could take many years for the results to come back, according to the FDA.

The new warning also states that long-term use of the drugs should be avoided and that the drugs aren't recommended for children younger than age 2.

Drugs Still Have Benefits

While the cancer studies are still being done, "there is a benefit associated with these drugs when used appropriately," states the FDA.

"For instance, they may be effective when other prescription topical medications do not work or are not advisable for the patient," the FDA says.

"The drugs are intended to be used for short periods, but if a patient requires a longer period of treatment, the treatment can be repeated after a period of time off treatment. Patients are advised to call their doctor if symptoms worsen, they develop an infection, or if symptoms do not improve within the six weeks of treatment."

Other drugs should be tried first, says the FDA.

About Eczema

Eczema, or atopic dermatitis, is one of the most common skin disorders seen in infants and children, affecting 10% to 15% of children. Its cause isn't known, but allergy or immune problems may be involved.

Patients have chronic itching and dry skin, which results in redness and skin damage from rubbing and scratching. Elidel and Protopic are applied to the skin to help control eczema.

Today on WebMD

woman meditating
Learn how to deal with a key trigger: stress.
Getting your eczema under control?
man with eczema
Does it affect your eczema?
makeup brushes and foundation
And be educated when shopping for cosmetics.
Antipsychotic Drugs Blood Clots
Eczema Emotional Effects
young woman touching skin
Eczema on arm

Itching for Relief?

Get Help With the

Loading ...

Sending your email...

This feature is temporarily unavailable. Please try again later.


Now check your email account on your mobile phone to download your new app.